Given the stage MSB is at the burn rate is reasonable. They have one product on the market in Japan and about to get FDA approval, and two with a reasonable chance of success late in phase 3. Even if both the phase 3 trials bomb, the GVHD treatment would support the current MC. The recent SP drop has knocked a lot of the premium out of the price and the risk to reward ratio looks good if you have a 12 to 24 month investment horizon. There is also the potential of a takeover or large partnership to act as positive surprise.
There is of course lots of risk (nothing in biotech is low risk), but as smallish part of a portfolio MSB looks attractive. This is why I have bought in and as you know I am highly skeptical of the sector as a whole.
- Forums
- ASX - By Stock
- MSB
- Mesoblast - takeover target?
Mesoblast - takeover target?, page-43
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 75212 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 1.185 |
1 | 20000 | 1.175 |
1 | 5664 | 1.170 |
1 | 17568 | 1.160 |
3 | 56695 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 59712 | 2 |
1.195 | 36255 | 5 |
1.200 | 404381 | 31 |
1.205 | 3000 | 1 |
1.210 | 162475 | 7 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |